Attached files

file filename
10-K - 10-K - Oncternal Therapeutics, Inc.onct-10k_20191231.htm
EX-32.2 - EX-32.2 - Oncternal Therapeutics, Inc.onct-ex322_692.htm
EX-32.1 - EX-32.1 - Oncternal Therapeutics, Inc.onct-ex321_691.htm
EX-31.2 - EX-31.2 - Oncternal Therapeutics, Inc.onct-ex312_693.htm
EX-31.1 - EX-31.1 - Oncternal Therapeutics, Inc.onct-ex311_694.htm
EX-23.1 - EX-23.1 - Oncternal Therapeutics, Inc.onct-ex231_10.htm
EX-10.32 - EX-10.32 - Oncternal Therapeutics, Inc.onct-ex1032_768.htm
EX-10.31 - EX-10.31 - Oncternal Therapeutics, Inc.onct-ex1031_767.htm
EX-10.13 - EX-10.13 - Oncternal Therapeutics, Inc.onct-ex1013_766.htm
EX-10.2 - EX-10.2 - Oncternal Therapeutics, Inc.onct-ex102_765.htm
EX-4.5 - EX-4.5 - Oncternal Therapeutics, Inc.onct-ex45_1133.htm

Exhibit 21.1

Subsidiaries

 

State of Incorporation

Oncternal Oncology, Inc.

 

Delaware

Oncternal, Inc.

 

Delaware

 

 

US-DOCS\114514280.1